Search Results - "Aizenstein, M L"

Refine Results
  1. 1

    Amphetamine, cocaine, and fencamfamine: relationship between locomotor and stereotypy response profiles and caudate and accumbens dopamine dynamics by Kuczenski, R, Segal, DS, Aizenstein, ML

    Published in The Journal of neuroscience (01-09-1991)
    “…Using in vivo microdialysis, the caudate and nucleus accumbens dopamine (DA) responses to the psychomotor stimulants amphetamine (AMPH), cocaine (COC), and…”
    Get full text
    Journal Article
  2. 2

    Repeated exposure of adolescent rats to oral methylphenidate does not induce behavioral sensitization or cross-sensitization to nicotine by Justo, C C, Carneiro-de-Oliveira, P E, Delucia, R, Aizenstein, M L, Planeta, C S

    “…Several lines of evidence indicate that the use of stimulant drugs, including methylphenidate (MPD), increases tobacco smoking. This has raised concerns that…”
    Get full text
    Journal Article
  3. 3

    Reinforcing properties of fencamfamine: Involvement of dopamine and opioid receptors by Da Silva Planeta, Cleopatra, Aizenstein, Moacyr Luiz, DeLucia, Roberto

    “…Fencamfamine (FCF) is a psychostimulant classified as an indirect dopamine agonist. The conditioning place preference (CPP) paradigm was used to investigate…”
    Get full text
    Journal Article
  4. 4

    Daily variation in plasma concentration of fencamfamine and striatal dopamine receptors in rats by Planeta, C S, DeLucia, R, Aizenstein, M L, Oliveira, G H

    “…Fencamfamine (FCF) is a psychostimulant drug classified as an indirect dopamine agonist. In the present study we evaluated the daily variation in plasma FCF…”
    Get more information
    Journal Article
  5. 5

    Circadian time-dependent effects of fencamfamine on inhibition of dopamine uptake and release in rat striatal slices by DeLucia, R, Planeta, C S, Ferreira, M P, Aizenstein, M L, Scavone, C

    “…Fencamfamine (FCF) is a central stimulant that facilitates central dopaminergic transmission through inhibition of dopamine uptake and enhanced release of the…”
    Get full text
    Journal Article
  6. 6

    The behavioral sensitization induced by fencamfamine is not related to plasma drug levels by Planeta, C S, DeLucia, R, Aizenstein, M L

    “…Fencamfamine (FCF) is a CNS stimulant that facilitates central dopaminergic transmission primarily through blockade of dopamine uptake. In the present study we…”
    Get more information
    Journal Article
  7. 7

    Effect of apomorphine on rat motor activity induced by fencamfamine and other indirect psychostimulant drugs by Aizenstein, M L, da-Silva-Planeta, C, DeLucia, R, da-Silva, C S

    “…We evaluated the effects of low doses of apomorphine on the stimulant behavioral effects induced by amphetamine (2.5 mg/kg), fencamfamine (6.0 mg/kg) and…”
    Get more information
    Journal Article
  8. 8

    Effect of fencamfamine on avoidance performances of rats by DeLucia, R, Aizenstein, M L, Planeta, C S

    “…The effects of fencamfamine (1.0 and 5.0 mg/kg, ip, single dose) on an inhibitory task were studied in rats (N = 15 per group). Post-training treatment with…”
    Get more information
    Journal Article
  9. 9

    On the mechanism which mediates the effects of long-term administration of fencamfamine in rats by Planeta, C S, DeLucia, R, Aizenstein, M L, Scavone, C

    “…This study analyzes the changes in the sensitivity of striatal dopaminergic (DA) receptors to apomorphine following withdrawal from long-term treatment with…”
    Get more information
    Journal Article
  10. 10

    The urinary excretion of 5-hydroxyindoleacetic acid does not reflect brain levels of this metabolite of 5-hydroxytryptamine by Aizenstein, M L, Scavone, C

    “…The present study was undertaken to determine if changes in the serotonergic central nervous system can be reflected by urinary 5-hydroxyindoleacetic acid…”
    Get more information
    Journal Article
  11. 11

    Repeated administration intensifies the reinforcing effect of fencamfamine in rats by DELUCIA, R, PLANETA, C. S, AIZENSTEIN, M. L, SCAVONE, C

    Published in General pharmacology (01-08-1997)
    “…1. In the present study, we evaluated the role of repeated administration on conditioning place preference (CPP) induced by fencamfamine (FCF) in male rats. 2…”
    Get full text
    Journal Article
  12. 12

    Evidence for a role of beta-endorphin in activity of nigrostriatal neurons in the rat by Lebrun, I, Lebrun, F L, Aizenstein, M L

    “…The effects of icv administration of beta-endorphin on secretory activity of dopaminergic neurons is described. Homovanillic and dihydroxyphenyl acetic acid…”
    Get more information
    Journal Article
  13. 13

    Behavioral and neurochemical effects of fencamfamine on rats: a chronobiologic approach by Planeta, C da S, Aizenstein, M L, Scavone, C, DeLucia, R

    Published in Chronobiology international (1989)
    “…Fencamfamine (FCF) is a psychostimulant classified as an indirect dopaminergic agonist. Circadian rhythms of some behavioral and neurochemical parameters were…”
    Get more information
    Journal Article
  14. 14

    Chronic imipramine administration reduces apomorphine inhibitory effects by Scavone, C, Aizenstein, M L, De Lucia, R, Da Silva Planeta, C

    Published in European journal of pharmacology (16-12-1986)
    “…Changes in activity of dopaminergic and serotonergic systems were assessed after acute and chronic (14 days) imipramine (10 mg/kg) administration in mice. For…”
    Get more information
    Journal Article
  15. 15

    Striatal dopamine receptor sensitivity after subchronic fencamfamine in the rat by Scavone, C, De Lucia, R, Bernardi, M M, Aizenstein, M L

    Published in European journal of pharmacology (01-01-1985)
    “…Dopamine (DA) receptor sensitivity was assessed in the rat striatal system following subchronic treatment with fencamfamine or saline for 7 days (10 mg/kg…”
    Get more information
    Journal Article
  16. 16

    Effects of fencamfamine withdrawal in rats by Planeta, C S, DeLucia, R, Aizenstein, M L

    Published in General pharmacology (01-09-1994)
    “…1. The effects produced by discontinuation of long-term treatment with fencamfamine (FCF) were evaluated recording behavioral and body weight changes. 2. 48 hr…”
    Get more information
    Journal Article
  17. 17

    Differential changes in dopaminergic receptor sensitivity induced by agonist drugs by Aizenstein, M L, Scavone, C, Steinschreiber, S, de-Lucia, R

    “…Mice were treated acutely or chronically with apomorphine (APO) (0.1 and 1.0 mg/kg) or L-DOPA (150 mg/kg) plus benserazide (50 mg/kg). The decrease of…”
    Get more information
    Journal Article
  18. 18

    Fencamfamine modulates sodium, potassium-ATPase through cyclic AMP and cyclic AMP-dependent protein kinase in rat striatum by PINTO FERREIRA, M, DELUCIA, R, AIZENSTEIN, M. L, GLEZER, I, SCAVONE, C

    Published in Journal of Neural Transmission (01-01-1998)
    “…Dopamine (DA) and fencamfamine (FCF) modulatory action on Na,K-ATPase and Mg-ATPase activity were evaluated in rat striatum. DA and FCF induced a decrease in…”
    Get full text
    Journal Article
  19. 19

    Repeated amphetamine and fencamfamine: sensitization and reciprocal cross-sensitization by Aizenstein, M L, Segal, D S, Kuczenski, R

    Published in Neuropsychopharmacology (New York, N.Y.) (01-08-1990)
    “…The repeated administration of amphetamine and related dopamine agonists results in an augmented or sensitized behavioral response to subsequent administration…”
    Get more information
    Journal Article
  20. 20

    Long-term effects of imipramine on striatal dopamine autoreceptor function: involvement of both noradrenergic and serotonergic systems by Scavone, C, Aizenstein, M L, Planeta, C da S, De Lucia, R

    Published in General pharmacology (01-05-1992)
    “…1. The effects of apomorphine (APO) administration on DA system activity were assessed by measuring dopamine metabolite levels (HVA) in several circumstances…”
    Get more information
    Journal Article